ADVANCED INTERVENTIONAL TECHNOLOGY, LLC
MIAMI, FLORIDA

Advanced Interventional Technology, LLC is a leading device representative specializing in medical imaging and oncology therapies. Established in 1992 with an emphasis on cardiovascular, neurovascular imaging, and oncology therapeutic sectors, the company provides optimal healthcare solutions to various institutions. Based in Miami, Florida, they primarily serve entities across the United States, South and Central America, and Europe. Originally founded by John Perez in 1985 with a vision of delivering innovative patient healthcare through nuclear medicine and radiographic imaging, the company has revolutionized diagnostic processes for chronic disorders using minimally invasive techniques. Today, Advanced Interventional Technology continues to champion these ideals by incorporating cutting-edge advancements in medical technology. The company is recognized as a hub center for communications and delivers a turnkey professional setup with comprehensive support services from inception through completion of projects. As a testament to their expertise, they are now 100% dedicated to promoting and selling the Proton Therapy ERHA for cancer treatment. Their legacy can be traced back to their early involvement in distributing X-Ray Equipment, CT Scans, and MRI machines since 1980, with notable expansion into products like Heart Technology's Rotablator during the 1990s. Advanced Interventional Technology adheres strictly to compliance standards as a Florida corporation, with its company status confirmed under the Florida Models DOS. They are located at Mailing Address: 6073 NW 167TH STREET STE. C-9, MIAMI, FL, 33015, and can be contacted via phone numbers (305) 828-7868 or (305) 828-7949. Their operations and achievements continue to contribute significantly to the medical sector's progression towards optimal healthcare solutions, as evidenced in their annual report dated January 29, 2024, with FEI Number: 030461775. The leadership structure includes Juan M Perez serving as President, continuing the organization's commitment to excellence and innovation in patient care technologies.